Referred to the Committee on Oversight and Government Reform, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each…
The Royalty Transparency Act amends executive-branch financial disclosure rules to require reporting and public disclosure of royalties received by certain federal employees and advisory committee members for inventions developed during government employment. It mandates GAO publication of advisory committees that make public-health recommendations, requires agencies to publish and provide reports (including confidential disclosures to Members of Congress), tightens waiver notifications to congressional committees, and instructs acquisition regulators to include royalty reviews in conflict-of-interest checks.
Liberty_left emphasizes protecting public-health integrity and exposing industry influence
Transparency and oversight bills often clear the House more readily; privacy and agency pushback may generate some opposition.
The Royalty Transparency Act amends executive-branch financial disclosure rules to require reporting and public disclosure of royalties received by certain federal employees and advisory committee members for inventions developed during government employment.
It mandates GAO publication of advisory committees that make public-health recommendations, requires agencies to publish and provide reports (including confidential disclosures to Members of Congress), tightens waiver notifications to congressional committees, and instructs acquisition regulators to include royalty reviews in conflict-of-interest checks.
Agencies must annually report identified royalty-related conflicts and mitigation steps; some provisions sunset or are time-limited.
Modest chance: non‑fiscal transparency goals help momentum, but privacy concerns, administrative burdens, and Senate hurdles reduce overall odds.
How solid the drafting looks.
Liberty_left emphasizes protecting public-health integrity and exposing industry influence
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberty_left emphasizes protecting public-health integrity and exposing industry influence
Likely broadly supportive because the bill increases transparency around royalties tied to government inventions and public-health advisory roles.
It addresses potential industry influence and seeks to make conflicts of interest public, aligning with accountability priorities.
Generally favorable but cautious; values transparency and conflict mitigation while worried about recruitment effects, privacy, operational burdens, and legal conflicts with existing IP statutes.
Would look for implementation details and cost-benefit clarity.
Mixed to skeptical: endorses transparency against undue influence but worries the bill expands federal intrusion into IP, harms commercialization incentives, and burdens agencies.
Concerned about privacy and chilling expert participation.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Modest chance: non‑fiscal transparency goals help momentum, but privacy concerns, administrative burdens, and Senate hurdles reduce overall odds.
The bill has not accumulated any surfaced votes yet.
Liberty_left emphasizes protecting public-health integrity and exposing industry influence
Modest chance: non‑fiscal transparency goals help momentum, but privacy concerns, administrative burdens, and Senate hurdles reduce overall…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Royalty Transparency Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.